Guanze Medical Information Industry (Holding) Co., Ltd.

Guanze Medical Information Industry (Holding) Co., Ltd.

2427.HK
Guanze Medical Information Industry (Holding) Co., Ltd.HK flagHong Kong Stock Exchange
2.42
HKD
-0.08
- -
2.30BMarket Cap
Guanze Medical Information Industry (Holding) Co., Ltd.
2427.HK
(Hong Kong Stock Exchange)

Recent

price

2.42

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
FRC
0.15
0.19
0.22
0.23
0.16
0.17
- -
Revenue per Share
0.02
0.03
0.02
0.02
0.03
0.02
- -
Basic EPS, GAAP
- -
0.01
-0.01
- -
- -
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.02
0.02
- -
Dividend per Share
- -
- -
0.11
0.16
0.14
0.14
- -
Book Value per Share
0.07
0.1
0.17
0.33
0.28
0.27
- -
Tangible Book Value per Share
950
950
950
766
950
939
- -
Basic Weighted Avg Shares
141
184
211
177
156
156
88
Sales/Revenue/Turnover
20.95
21.77
15.93
17.42
25.77
20.22
-17.36
Operating Margin (%)
2
3
4
5
6
7
16
Depreciation Expense
22
29
23
18
28
17
-30
Net Income, GAAP
24.57
25.54
30.22
38.97
27.76
33.67
- -
Effective Tax Rate (%)
15.85
15.75
10.87
10.13
17.66
11.05
-33.6
Profit Margin (%)
58
74
132
226
230
202
175
Working Capital
- -
4
- -
- -
- -
- -
- -
LT Debt
74
98
163
261
270
261
232
Total Equity
- -
30.7
15.94
7.96
9.83
7.09
- -
Return on Invested Capital (%)
- -
615.12
37.11
13.6
18.15
11.4
- -
Return on Capital (%)
- -
- -
45.34
15.84
21.39
13.04
-25.49
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
22.94%
-10.84%
Free Cash Flow
- -
-2,413.92%
-1.99%
Net Income, GAAP
- -
-59.9%
-272.73%
Sales/Revenue/Turnover
- -
-11.39%
-43.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
156
2024
- -
- -
- -
- -
156
2025
- -
- -
- -
- -
88

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.03
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
- -
Business
Guanze Medical Information Industry (Holding) Co., Ltd. engages in the provision of medical imaging solutions in the People's Republic of China, with a focus on medical imaging film products and cloud-based imaging services. The company operates as an investment holding entity, with core activities centered on the research, development, sale, and maintenance of medical imaging materials and associated information technology platforms. Headquartered in Jinan, China, Guanze maintains a corporate structure that includes subsidiaries dedicated to manufacturing and distributing imaging films, as well as delivering cloud-based medical imaging solutions and related digital platforms. The firm markets imaging films to hospitals and healthcare institutions, while also offering digital medical imaging cloud storage platforms, digital image platforms, regional imaging diagrams platforms, and Picture Archiving and Communication System (PACS) solutions. Additional revenue streams arise from the sale of self-service film output printers, medical image printers, and data distribution systems, alongside maintenance and leasing of medical devices. The company’s operations span across China, with strategic emphasis on expanding market presence in Shandong Province and broader eastern regions, leveraging brand promotion, industry exhibitions, and IT system upgrades to enhance service delivery. Guanze was founded in 2015 and is publicly listed on the Hong Kong Stock Exchange (ticker: 2427.HK), with a corporate headquarters in Jinan and an implied corporate structure that includes a Cayman Islands entity as the primary holding vehicle. The company’s geographic footprint includes mainland China operations and related regional service networks, aiming to serve hospitals, clinics, and other healthcare providers with integrated imaging film products and cloud-based imaging services. The latest major changes include strategic expansions in product offerings and value chain development, ongoing acquisitions and registrations to broaden device capabilities, and initiatives to upgrade IT systems and broaden market reach through exhibitions and brand initiatives.